Abstract:A dually‐layered "microneedle rocket" is designed for melanoma treatment. The upper layer consists of mesoporous silica nanoparticles covalently bonded with a photosensitizer (PcNP) alongside a targeted therapy drugs (TRA). The lower layer comprises a hydrogel matrix with controllable cross‐linking density encapsulating collagenase (CLG) for remodeling the extracellular matrix (ECM). The rocket‐like microneedles achieve deep penetration of nanoparticles (PcNP/TRA) for efficacious photodynamic therapy and targeted therapy. Photodynamic therapy (PDT) proves highly effective in addressing melanoma, and its synergy with targeted therapy offers a promising avenue in tumor treatment. However, the therapeutic outcome is largely impeded by the challenge of current photosensitizers and targeted drugs in reaching deep tumor tissues. Herein, a dually‐layered "microneedle rocket" termed PcNP/TRA‐HA‐Tyr/CLG‐MN is designed. The upper layer of the microneedle (MN) is composed of photodynamically active mesoporous silica nanoparticles, featuring photosensitizers covalently bonded to them. Within the mesopores of these nanoparticles lies trametinib (TRA), a compound that specifically targets the hyperactive MEK pathway present in melanoma cells. The lower layer is composed of an enzyme‐mediated hyaluronic acid‐tyramine hydrogel (HA‐Tyr/CLG) with collagenase (CLG), serving as rocket thrusters for remodeling the extracellular matrix (ECM) in tumor microenvironment. Among the three types of MNs prepared, the PcNP/TRA‐HA‐Tyr(II)/CLG‐MN exhibits the deepest penetration in tumor tissues and the longest retention time in vivo. Notably, the administrations of PcNP/TRA‐HA‐Tyr(II)/CLG‐MN alongside light irradiation significantly suppress the growth of A375‐xenografted tumors in mice. Together, the strategy of combining mesoporous silica nanoparticles, enzymatically cross‐linked hydrogels and CLG‐mediated ECM remodeling enables deep drug penetration and efficacious combination treatment against melanoma, showcasing significant potential in the realm of cancer nanomedicine.

Steerable Microneedles Enabling Deep Delivery of Photosensitizers and CRISPR/Cas9 Systems for Effective Combination Cancer Therapy

Unique Photochemo-Immuno-Nanoplatform Against Orthotopic Xenograft Oral Cancer and Metastatic Syngeneic Breast Cancer.

Rapidly Dissolving Microneedle Patch for Synergistic Gene and Photothermal Therapy of Subcutaneous Tumor

A DNA/Upconversion Nanoparticle Complex Enables Controlled Co‐Delivery of CRISPR‐Cas9 and Photodynamic Agents for Synergistic Cancer Therapy

Construction of microneedle-assisted co-delivery platform and its combining photodynamic/immunotherapy

Microneedle‐Loaded Gene‐Editable Nanohybrids Engineer Cancer Cells by Telomere Stress Induction and Metabolic Interference for Enhanced Cuproptosis and Immunotherapy

A Multifunctional Rocket‐Like Microneedle System with Thrusters for Self‐Promoted Deep Drug Penetration and Combination Treatment in Melanoma

Photosensitizer-immunotherapy integrated microneedles for preventing tumor recurrence and metastasis

Build an implanted "arsenal": detachable microneedles for NIR-triggered cancer photothermo-chemotherapy

A dual-sensitive nanoparticle-mediated deepening synergistic therapy strategy involving DNA damage and ICD stimuli to treat triple-negative breast cancer

CRISPR/Cas9‐2D Silicene Gene‐Editing Nanosystem for Remote NIR‐II‐Induced Tumor Microenvironment Reprogramming and Augmented Photonic Tumor Ablation

The microneedles carrying cisplatin and IR820 to perform synergistic chemo-photodynamic therapy against breast cancer

Tumor microenvironment responsive nano-herb and CRISPR delivery system for synergistic chemotherapy and immunotherapy

Microneedle-Assisted Topical Delivery of Photodynamically Active Mesoporous Formulation for Combination Therapy of Deep-Seated Melanoma

Co-delivery of Doxorubicin and CRISPR/Cas9 or RNAi-expressing Plasmid by Chitosan-Based Nanoparticle for Cancer Therapy.

Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment

Multimicrochannel Microneedle Microporation Platform for Enhanced Intracellular Drug Delivery

A cancer cell membrane‐derived biomimetic nanocarrier for synergistic photothermal/gene therapy by efficient delivery of CRISPR/Cas9 and gold nanorods

Cancer Therapy: Light‐Activatable Assembled Nanoparticles to Improve Tumor Penetration and Eradicate Metastasis in Triple Negative Breast Cancer (adv. Funct. Mater. 33/2018)

Photo-excitable Hybrid Nanocomposites for Image-Guided Photo/trail Synergistic Cancer Therapy.

Microneedle-mediated treatment for superficial tumors by combining multiple strategies